Related Experiment Video
Updated: Aug 24, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
isomiRTar: a comprehensive portal of pan-cancer 5'-isomiR targeting
Stepan Nersisyan1,2,3,4, Aleksandra Gorbonos4, Alexey Makhonin4
1Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Abstract:
Inaccurate cleavage of pri- and pre-miRNA hairpins by Drosha and Dicer results in the generation of miRNA isoforms known as isomiRs. isomiRs with 5'-end variations (5'-isomiRs) create a new dimension in miRNA research since they have different seed regions and distinct targetomes. We developed isomiRTar (https://isomirtar.hse.ru)-a comprehensive portal that allows one to analyze expression profiles and targeting activity of 5'-isomiRs in cancer. Using the Cancer Genome Atlas sequencing data, we compiled the list of 1022 5'-isomiRs expressed in 9282 tumor samples across 31 cancer types. Sequences of these isomiRs were used to predict target genes with miRDB and TargetScan. The putative interactions were then subjected to the co-expression analysis in each cancer type to identify isomiR-target pairs supported by significant negative correlations. Downstream analysis of the data deposited in isomiRTar revealed both cancer-specific and cancer-conserved 5'-isomiR expression landscapes. Pairs of isomiRs differing in one nucleotide shift from 5'-end had poorly overlapping targetomes with the median Jaccard index of 0.06. The analysis of colorectal cancer 5'-isomiR-mediated regulatory networks revealed promising candidate tumor suppressor isomiRs: hsa-miR-203a-3p-+1, hsa-miR-192-5p-+1 and hsa-miR-148a-3p-0. In summary, we believe that isomiRTar will help researchers find novel mechanisms of isomiR-mediated gene silencing in different types of cancer.
Insights
MicroRNA (miRNA) isoforms, or isomiRs, with 5'-end variations (5'-isomiRs) have distinct targets in cancer. The isomiRTar portal analyzes these 5'-isomiRs, revealing cancer-specific landscapes and potential tumor suppressors.
Area of Science:
- Molecular Biology
- Genomics
- Bioinformatics
Background:
- MicroRNAs (miRNAs) regulate gene expression through specific seed regions.
- Inaccurate processing of miRNA precursors generates miRNA isoforms known as isomiRs.
- IsomiRs with 5'-end variations (5'-isomiRs) possess distinct seed regions and targetomes, impacting gene regulation.
Purpose of the Study:
- To develop isomiRTar, a comprehensive portal for analyzing 5'-isomiR expression and targeting in cancer.
- To identify and characterize 5'-isomiRs across various cancer types using The Cancer Genome Atlas (TCGA) data.
Main Methods:
- Compiled a list of 1022 5'-isomiRs from 9282 tumor samples across 31 cancer types using TCGA data.
- Predicted target genes for identified 5'-isomiRs using miRDB and TargetScan.
- Performed co-expression analysis to identify robust isomiR-target pairs with significant negative correlations.
Main Results:
- Discovered distinct cancer-specific and conserved 5'-isomiR expression patterns.
- Demonstrated that 5'-isomiRs differing by a single nucleotide shift have largely non-overlapping targetomes (median Jaccard index of 0.06).
- Identified potential tumor suppressor 5'-isomiRs in colorectal cancer, including hsa-miR-203a-3p-+1, hsa-miR-192-5p-+1, and hsa-miR-148a-3p-0.
Conclusions:
- The isomiRTar portal provides a valuable resource for exploring 5'-isomiR expression and targeting in cancer.
- 5'-isomiR variations contribute to the complexity of miRNA-mediated gene silencing.
- This resource facilitates the discovery of novel isomiR-mediated regulatory mechanisms in cancer biology.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Treatment Resistant Cancers
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...